e-learning
resources
London 2016
Sunday, 04.09.2016
Molecular pathways of smoking-induced diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers
Marta Maskey-Warzechowska (Warsaw, Poland), Marta Maskey-Warzechowska, Patrycja Nejman-Gryz, Katarzyna Osinka, Paulina Lis, Kamila Malesa, Katarzyna Gorska, Rafal Krenke
Source:
International Congress 2016 – Molecular pathways of smoking-induced diseases
Session:
Molecular pathways of smoking-induced diseases
Session type:
Oral Presentation
Number:
1484
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Marta Maskey-Warzechowska (Warsaw, Poland), Marta Maskey-Warzechowska, Patrycja Nejman-Gryz, Katarzyna Osinka, Paulina Lis, Kamila Malesa, Katarzyna Gorska, Rafal Krenke. The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers. Eur Respir J 2016; 48: Suppl. 60, 1484
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Decreased levels of bis-S-bimane in exhaled breath condensate of COPD
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Biomarker reproducibility study in exhaled breath and induced sputum in nonsmokers, smokers and COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 77s
Year: 2003
8-isoprostane in exhaled breath condensate in healthy and asthmatic children, and its relationship with tobacco smoke exposure
Source: Annual Congress 2011 - Inflammation and genes in childhood asthma
Year: 2011
Dynamics of exhaled breath temperature (EBT) after a smoked cigarette
Source: International Congress 2016 – New approaches and finding in smoking cessation
Year: 2016
Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008
Exhaled breath temperature as a possible early marker in smokers at risk for COPD (MARKO study)
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Comparison of breath VOCs collected from controls, healthy smokers, smokers with COPD, and ex-smokers with COPD at two sites
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Exhaled breath condensate (EBC): what is sampled and how should it be collected? (recommendations and open issues)
Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate
Year: 2007
Cross sectional analysis of inflammatory mediators in exhaled breath condensate from COPD patients and healthy smoking controls
Source: Annual Congress 2007 - Mechanisms and new treatments of COPD
Year: 2007
Influence of inflammatory phenotype in severe refractory asthma on metabolomic profile of oxidative stress in exhaled breath condensate (EBC)
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Influence of smoking on indicators of free-radical oxidation in a condensate in exhaled breath condensate (EBC) at healthy and patients with bronchial asthma (BA)
Source: Annual Congress 2010 - Smoking related disorders
Year: 2010
Alcohol metabolites are detectable in exhaled breath of healthy, unaffected by a breath holding maneuver and may serve as novel pro-inflammatory biomarkers in asthma and COPD
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008
Periostin in exhaled breath condensate as a biomarker of different severe asthma phenotypes.
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017
Exhaled breath condensate sample collection: standards and open issues
Source: Eur Respir Monogr 2010; 49: 152-161
Year: 2010
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
8-isoprostane in breath condensate in patients with exacerbation of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 248s
Year: 2001
Exhaled breath condensate for evaluation of inflammation in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006
pH in exhaled breath condensate of patients with stable COPD: associations with disease severity and pulmonary function tests
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009
The biomarkers of atopy in exhaled breath condensate in patients with bronchial asthma
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept